title: Author reply: To PMID 23021093.
authors.forename: Rufino
authors.initials: R
authors.lastname: Silva
authors.forename: Ruth
authors.initials: R
authors.lastname: Axer-Siegel
authors.forename: Bora
authors.initials: B
authors.lastname: Eldem
authors.forename: Robyn
authors.initials: R
authors.lastname: Guymer
authors.forename: Bernd
authors.initials: B
authors.lastname: Kirchhof
authors.forename: Andras
authors.initials: A
authors.lastname: Papp
authors.forename: Andras
authors.initials: A
authors.lastname: Seres
authors.forename: Margarita
authors.initials: M
authors.lastname: Gekkieva
authors.forename: Annette
authors.initials: A
authors.lastname: Nieweg
authors.forename: Stefan
authors.initials: S
authors.lastname: Pilz
mesh_terms: D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D057135:Wet Macular Degeneration / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized